Loma Linda Offers Cutting-Edge New Cancer Treatment

23 November 2022 | Loma Linda University Cancer Center is offering a new immunotherapy treatment for those who suffer from a type of eye cancer called ocular or uveal melanoma. The treatment, called Tebentafusp-tebn, was approved by the FDA earlier this year. “This is a welcome addition to our portfolio of medications and marks an […]